Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neutropenia Biologic Drug Treatment Market Size Growth Rate by Type: 2018 VS 2024 VS 2034
1.2.2 Filgrastim
1.2.3 Pegfilgrastim
1.2.4 Lenograstim
1.2.5 Lipegfilgrastim
1.2.6 Sargramostim
1.3 Market by Application
1.3.1 Global Neutropenia Biologic Drug Treatment Market Growth by Application: 2018 VS 2024 VS 2034
1.3.2 Retail Pharmacies
1.3.3 Hospital Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Neutropenia Biologic Drug Treatment Market Perspective (2018-2034)
2.2 Neutropenia Biologic Drug Treatment Growth Trends by Region
2.2.1 Global Neutropenia Biologic Drug Treatment Market Size by Region: 2018 VS 2024 VS 2034
2.2.2 Neutropenia Biologic Drug Treatment Historic Market Size by Region (2018-2023)
2.2.3 Neutropenia Biologic Drug Treatment Forecasted Market Size by Region (2024-2034)
2.3 Neutropenia Biologic Drug Treatment Market Dynamics
2.3.1 Neutropenia Biologic Drug Treatment Industry Trends
2.3.2 Neutropenia Biologic Drug Treatment Market Drivers
2.3.3 Neutropenia Biologic Drug Treatment Market Challenges
2.3.4 Neutropenia Biologic Drug Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neutropenia Biologic Drug Treatment Players by Revenue
3.1.1 Global Top Neutropenia Biologic Drug Treatment Players by Revenue (2018-2023)
3.1.2 Global Neutropenia Biologic Drug Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Neutropenia Biologic Drug Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Neutropenia Biologic Drug Treatment Revenue
3.4 Global Neutropenia Biologic Drug Treatment Market Concentration Ratio
3.4.1 Global Neutropenia Biologic Drug Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neutropenia Biologic Drug Treatment Revenue in 2024
3.5 Neutropenia Biologic Drug Treatment Key Players Head office and Area Served
3.6 Key Players Neutropenia Biologic Drug Treatment Product Solution and Service
3.7 Date of Enter into Neutropenia Biologic Drug Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Neutropenia Biologic Drug Treatment Breakdown Data by Type
4.1 Global Neutropenia Biologic Drug Treatment Historic Market Size by Type (2018-2023)
4.2 Global Neutropenia Biologic Drug Treatment Forecasted Market Size by Type (2024-2034)
5 Neutropenia Biologic Drug Treatment Breakdown Data by Application
5.1 Global Neutropenia Biologic Drug Treatment Historic Market Size by Application (2018-2023)
5.2 Global Neutropenia Biologic Drug Treatment Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Neutropenia Biologic Drug Treatment Market Size (2018-2034)
6.2 North America Neutropenia Biologic Drug Treatment Market Growth Rate by Country: 2018 VS 2024 VS 2034
6.3 North America Neutropenia Biologic Drug Treatment Market Size by Country (2018-2023)
6.4 North America Neutropenia Biologic Drug Treatment Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Neutropenia Biologic Drug Treatment Market Size (2018-2034)
7.2 Europe Neutropenia Biologic Drug Treatment Market Growth Rate by Country: 2018 VS 2024 VS 2034
7.3 Europe Neutropenia Biologic Drug Treatment Market Size by Country (2018-2023)
7.4 Europe Neutropenia Biologic Drug Treatment Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Neutropenia Biologic Drug Treatment Market Size (2018-2034)
8.2 Asia-Pacific Neutropenia Biologic Drug Treatment Market Growth Rate by Region: 2018 VS 2024 VS 2034
8.3 Asia-Pacific Neutropenia Biologic Drug Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Neutropenia Biologic Drug Treatment Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Neutropenia Biologic Drug Treatment Market Size (2018-2034)
9.2 Latin America Neutropenia Biologic Drug Treatment Market Growth Rate by Country: 2018 VS 2024 VS 2034
9.3 Latin America Neutropenia Biologic Drug Treatment Market Size by Country (2018-2023)
9.4 Latin America Neutropenia Biologic Drug Treatment Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neutropenia Biologic Drug Treatment Market Size (2018-2034)
10.2 Middle East & Africa Neutropenia Biologic Drug Treatment Market Growth Rate by Country: 2018 VS 2024 VS 2034
10.3 Middle East & Africa Neutropenia Biologic Drug Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Neutropenia Biologic Drug Treatment Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Detail
11.1.2 Amgen Business Overview
11.1.3 Amgen Neutropenia Biologic Drug Treatment Introduction
11.1.4 Amgen Revenue in Neutropenia Biologic Drug Treatment Business (2018-2023)
11.1.5 Amgen Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Neutropenia Biologic Drug Treatment Introduction
11.2.4 Novartis Revenue in Neutropenia Biologic Drug Treatment Business (2018-2023)
11.2.5 Novartis Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Neutropenia Biologic Drug Treatment Introduction
11.3.4 Pfizer Revenue in Neutropenia Biologic Drug Treatment Business (2018-2023)
11.3.5 Pfizer Recent Development
11.4 Baxter International
11.4.1 Baxter International Company Detail
11.4.2 Baxter International Business Overview
11.4.3 Baxter International Neutropenia Biologic Drug Treatment Introduction
11.4.4 Baxter International Revenue in Neutropenia Biologic Drug Treatment Business (2018-2023)
11.4.5 Baxter International Recent Development
11.5 Cellerant Therapeutics
11.5.1 Cellerant Therapeutics Company Detail
11.5.2 Cellerant Therapeutics Business Overview
11.5.3 Cellerant Therapeutics Neutropenia Biologic Drug Treatment Introduction
11.5.4 Cellerant Therapeutics Revenue in Neutropenia Biologic Drug Treatment Business (2018-2023)
11.5.5 Cellerant Therapeutics Recent Development
11.6 Dong-A ST Co.,Ltd.
11.6.1 Dong-A ST Co.,Ltd. Company Detail
11.6.2 Dong-A ST Co.,Ltd. Business Overview
11.6.3 Dong-A ST Co.,Ltd. Neutropenia Biologic Drug Treatment Introduction
11.6.4 Dong-A ST Co.,Ltd. Revenue in Neutropenia Biologic Drug Treatment Business (2018-2023)
11.6.5 Dong-A ST Co.,Ltd. Recent Development
11.7 Myelo Therapeutics GmbH
11.7.1 Myelo Therapeutics GmbH Company Detail
11.7.2 Myelo Therapeutics GmbH Business Overview
11.7.3 Myelo Therapeutics GmbH Neutropenia Biologic Drug Treatment Introduction
11.7.4 Myelo Therapeutics GmbH Revenue in Neutropenia Biologic Drug Treatment Business (2018-2023)
11.7.5 Myelo Therapeutics GmbH Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Detail
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Neutropenia Biologic Drug Treatment Introduction
11.8.4 Sanofi Revenue in Neutropenia Biologic Drug Treatment Business (2018-2023)
11.8.5 Sanofi Recent Development
11.9 Teva Pharmaceutical Industries Ltd.
11.9.1 Teva Pharmaceutical Industries Ltd. Company Detail
11.9.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.9.3 Teva Pharmaceutical Industries Ltd. Neutropenia Biologic Drug Treatment Introduction
11.9.4 Teva Pharmaceutical Industries Ltd. Revenue in Neutropenia Biologic Drug Treatment Business (2018-2023)
11.9.5 Teva Pharmaceutical Industries Ltd. Recent Development
11.10 Kyowa Kirin
11.10.1 Kyowa Kirin Company Detail
11.10.2 Kyowa Kirin Business Overview
11.10.3 Kyowa Kirin Neutropenia Biologic Drug Treatment Introduction
11.10.4 Kyowa Kirin Revenue in Neutropenia Biologic Drug Treatment Business (2018-2023)
11.10.5 Kyowa Kirin Recent Development
11.11 CVS Health
11.11.1 CVS Health Company Detail
11.11.2 CVS Health Business Overview
11.11.3 CVS Health Neutropenia Biologic Drug Treatment Introduction
11.11.4 CVS Health Revenue in Neutropenia Biologic Drug Treatment Business (2018-2023)
11.11.5 CVS Health Recent Development
11.12 Partner Therapeutics
11.12.1 Partner Therapeutics Company Detail
11.12.2 Partner Therapeutics Business Overview
11.12.3 Partner Therapeutics Neutropenia Biologic Drug Treatment Introduction
11.12.4 Partner Therapeutics Revenue in Neutropenia Biologic Drug Treatment Business (2018-2023)
11.12.5 Partner Therapeutics Recent Development
11.13 Enzychem Lifesciences Corporation
11.13.1 Enzychem Lifesciences Corporation Company Detail
11.13.2 Enzychem Lifesciences Corporation Business Overview
11.13.3 Enzychem Lifesciences Corporation Neutropenia Biologic Drug Treatment Introduction
11.13.4 Enzychem Lifesciences Corporation Revenue in Neutropenia Biologic Drug Treatment Business (2018-2023)
11.13.5 Enzychem Lifesciences Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Neutropenia Biologic Drug Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2024 VS 2034
Table 2. Key Players of Filgrastim
Table 3. Key Players of Pegfilgrastim
Table 4. Key Players of Lenograstim
Table 5. Key Players of Lipegfilgrastim
Table 6. Key Players of Sargramostim
Table 7. Global Neutropenia Biologic Drug Treatment Market Size Growth by Application (US$ Million): 2018 VS 2024 VS 2034
Table 8. Global Neutropenia Biologic Drug Treatment Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 9. Global Neutropenia Biologic Drug Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Neutropenia Biologic Drug Treatment Market Share by Region (2018-2023)
Table 11. Global Neutropenia Biologic Drug Treatment Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 12. Global Neutropenia Biologic Drug Treatment Market Share by Region (2024-2034)
Table 13. Neutropenia Biologic Drug Treatment Market Trends
Table 14. Neutropenia Biologic Drug Treatment Market Drivers
Table 15. Neutropenia Biologic Drug Treatment Market Challenges
Table 16. Neutropenia Biologic Drug Treatment Market Restraints
Table 17. Global Neutropenia Biologic Drug Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Neutropenia Biologic Drug Treatment Market Share by Players (2018-2023)
Table 19. Global Top Neutropenia Biologic Drug Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neutropenia Biologic Drug Treatment as of 2024)
Table 20. Ranking of Global Top Neutropenia Biologic Drug Treatment Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Neutropenia Biologic Drug Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Neutropenia Biologic Drug Treatment Product Solution and Service
Table 24. Date of Enter into Neutropenia Biologic Drug Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Neutropenia Biologic Drug Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Neutropenia Biologic Drug Treatment Revenue Market Share by Type (2018-2023)
Table 28. Global Neutropenia Biologic Drug Treatment Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 29. Global Neutropenia Biologic Drug Treatment Revenue Market Share by Type (2024-2034)
Table 30. Global Neutropenia Biologic Drug Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Neutropenia Biologic Drug Treatment Revenue Market Share by Application (2018-2023)
Table 32. Global Neutropenia Biologic Drug Treatment Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 33. Global Neutropenia Biologic Drug Treatment Revenue Market Share by Application (2024-2034)
Table 34. North America Neutropenia Biologic Drug Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 35. North America Neutropenia Biologic Drug Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Neutropenia Biologic Drug Treatment Market Size by Country (2024-2034) & (US$ Million)
Table 37. Europe Neutropenia Biologic Drug Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 38. Europe Neutropenia Biologic Drug Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Neutropenia Biologic Drug Treatment Market Size by Country (2024-2034) & (US$ Million)
Table 40. Asia-Pacific Neutropenia Biologic Drug Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2024 VS 2034
Table 41. Asia-Pacific Neutropenia Biologic Drug Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Neutropenia Biologic Drug Treatment Market Size by Region (2024-2034) & (US$ Million)
Table 43. Latin America Neutropenia Biologic Drug Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 44. Latin America Neutropenia Biologic Drug Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Neutropenia Biologic Drug Treatment Market Size by Country (2024-2034) & (US$ Million)
Table 46. Middle East & Africa Neutropenia Biologic Drug Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 47. Middle East & Africa Neutropenia Biologic Drug Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Neutropenia Biologic Drug Treatment Market Size by Country (2024-2034) & (US$ Million)
Table 49. Amgen Company Detail
Table 50. Amgen Business Overview
Table 51. Amgen Neutropenia Biologic Drug Treatment Product
Table 52. Amgen Revenue in Neutropenia Biologic Drug Treatment Business (2018-2023) & (US$ Million)
Table 53. Amgen Recent Development
Table 54. Novartis Company Detail
Table 55. Novartis Business Overview
Table 56. Novartis Neutropenia Biologic Drug Treatment Product
Table 57. Novartis Revenue in Neutropenia Biologic Drug Treatment Business (2018-2023) & (US$ Million)
Table 58. Novartis Recent Development
Table 59. Pfizer Company Detail
Table 60. Pfizer Business Overview
Table 61. Pfizer Neutropenia Biologic Drug Treatment Product
Table 62. Pfizer Revenue in Neutropenia Biologic Drug Treatment Business (2018-2023) & (US$ Million)
Table 63. Pfizer Recent Development
Table 64. Baxter International Company Detail
Table 65. Baxter International Business Overview
Table 66. Baxter International Neutropenia Biologic Drug Treatment Product
Table 67. Baxter International Revenue in Neutropenia Biologic Drug Treatment Business (2018-2023) & (US$ Million)
Table 68. Baxter International Recent Development
Table 69. Cellerant Therapeutics Company Detail
Table 70. Cellerant Therapeutics Business Overview
Table 71. Cellerant Therapeutics Neutropenia Biologic Drug Treatment Product
Table 72. Cellerant Therapeutics Revenue in Neutropenia Biologic Drug Treatment Business (2018-2023) & (US$ Million)
Table 73. Cellerant Therapeutics Recent Development
Table 74. Dong-A ST Co.,Ltd. Company Detail
Table 75. Dong-A ST Co.,Ltd. Business Overview
Table 76. Dong-A ST Co.,Ltd. Neutropenia Biologic Drug Treatment Product
Table 77. Dong-A ST Co.,Ltd. Revenue in Neutropenia Biologic Drug Treatment Business (2018-2023) & (US$ Million)
Table 78. Dong-A ST Co.,Ltd. Recent Development
Table 79. Myelo Therapeutics GmbH Company Detail
Table 80. Myelo Therapeutics GmbH Business Overview
Table 81. Myelo Therapeutics GmbH Neutropenia Biologic Drug Treatment Product
Table 82. Myelo Therapeutics GmbH Revenue in Neutropenia Biologic Drug Treatment Business (2018-2023) & (US$ Million)
Table 83. Myelo Therapeutics GmbH Recent Development
Table 84. Sanofi Company Detail
Table 85. Sanofi Business Overview
Table 86. Sanofi Neutropenia Biologic Drug Treatment Product
Table 87. Sanofi Revenue in Neutropenia Biologic Drug Treatment Business (2018-2023) & (US$ Million)
Table 88. Sanofi Recent Development
Table 89. Teva Pharmaceutical Industries Ltd. Company Detail
Table 90. Teva Pharmaceutical Industries Ltd. Business Overview
Table 91. Teva Pharmaceutical Industries Ltd. Neutropenia Biologic Drug Treatment Product
Table 92. Teva Pharmaceutical Industries Ltd. Revenue in Neutropenia Biologic Drug Treatment Business (2018-2023) & (US$ Million)
Table 93. Teva Pharmaceutical Industries Ltd. Recent Development
Table 94. Kyowa Kirin Company Detail
Table 95. Kyowa Kirin Business Overview
Table 96. Kyowa Kirin Neutropenia Biologic Drug Treatment Product
Table 97. Kyowa Kirin Revenue in Neutropenia Biologic Drug Treatment Business (2018-2023) & (US$ Million)
Table 98. Kyowa Kirin Recent Development
Table 99. CVS Health Company Detail
Table 100. CVS Health Business Overview
Table 101. CVS Health Neutropenia Biologic Drug Treatment Product
Table 102. CVS Health Revenue in Neutropenia Biologic Drug Treatment Business (2018-2023) & (US$ Million)
Table 103. CVS Health Recent Development
Table 104. Partner Therapeutics Company Detail
Table 105. Partner Therapeutics Business Overview
Table 106. Partner Therapeutics Neutropenia Biologic Drug Treatment Product
Table 107. Partner Therapeutics Revenue in Neutropenia Biologic Drug Treatment Business (2018-2023) & (US$ Million)
Table 108. Partner Therapeutics Recent Development
Table 109. Enzychem Lifesciences Corporation Company Detail
Table 110. Enzychem Lifesciences Corporation Business Overview
Table 111. Enzychem Lifesciences Corporation Neutropenia Biologic Drug Treatment Product
Table 112. Enzychem Lifesciences Corporation Revenue in Neutropenia Biologic Drug Treatment Business (2018-2023) & (US$ Million)
Table 113. Enzychem Lifesciences Corporation Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Neutropenia Biologic Drug Treatment Market Size Comparison by Type (2023-2034) & (US$ Million)
Figure 2. Global Neutropenia Biologic Drug Treatment Market Share by Type: 2024 VS 2034
Figure 3. Filgrastim Features
Figure 4. Pegfilgrastim Features
Figure 5. Lenograstim Features
Figure 6. Lipegfilgrastim Features
Figure 7. Sargramostim Features
Figure 8. Global Neutropenia Biologic Drug Treatment Market Size Comparison by Application (2023-2034) & (US$ Million)
Figure 9. Global Neutropenia Biologic Drug Treatment Market Share by Application: 2024 VS 2034
Figure 10. Retail Pharmacies Case Studies
Figure 11. Hospital Pharmacies Case Studies
Figure 12. Online Pharmacies Case Studies
Figure 13. Neutropenia Biologic Drug Treatment Report Years Considered
Figure 14. Global Neutropenia Biologic Drug Treatment Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 15. Global Neutropenia Biologic Drug Treatment Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 16. Global Neutropenia Biologic Drug Treatment Market Share by Region: 2024 VS 2034
Figure 17. Global Neutropenia Biologic Drug Treatment Market Share by Players in 2024
Figure 18. Global Top Neutropenia Biologic Drug Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neutropenia Biologic Drug Treatment as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Neutropenia Biologic Drug Treatment Revenue in 2024
Figure 20. North America Neutropenia Biologic Drug Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 21. North America Neutropenia Biologic Drug Treatment Market Share by Country (2018-2034)
Figure 22. United States Neutropenia Biologic Drug Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 23. Canada Neutropenia Biologic Drug Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 24. Europe Neutropenia Biologic Drug Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 25. Europe Neutropenia Biologic Drug Treatment Market Share by Country (2018-2034)
Figure 26. Germany Neutropenia Biologic Drug Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. France Neutropenia Biologic Drug Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. U.K. Neutropenia Biologic Drug Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. Italy Neutropenia Biologic Drug Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. Russia Neutropenia Biologic Drug Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Nordic Countries Neutropenia Biologic Drug Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. Asia-Pacific Neutropenia Biologic Drug Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. Asia-Pacific Neutropenia Biologic Drug Treatment Market Share by Region (2018-2034)
Figure 34. China Neutropenia Biologic Drug Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. Japan Neutropenia Biologic Drug Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. South Korea Neutropenia Biologic Drug Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. Southeast Asia Neutropenia Biologic Drug Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 38. India Neutropenia Biologic Drug Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 39. Australia Neutropenia Biologic Drug Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 40. Latin America Neutropenia Biologic Drug Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 41. Latin America Neutropenia Biologic Drug Treatment Market Share by Country (2018-2034)
Figure 42. Mexico Neutropenia Biologic Drug Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. Brazil Neutropenia Biologic Drug Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 44. Middle East & Africa Neutropenia Biologic Drug Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 45. Middle East & Africa Neutropenia Biologic Drug Treatment Market Share by Country (2018-2034)
Figure 46. Turkey Neutropenia Biologic Drug Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 47. Saudi Arabia Neutropenia Biologic Drug Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 48. Amgen Revenue Growth Rate in Neutropenia Biologic Drug Treatment Business (2018-2023)
Figure 49. Novartis Revenue Growth Rate in Neutropenia Biologic Drug Treatment Business (2018-2023)
Figure 50. Pfizer Revenue Growth Rate in Neutropenia Biologic Drug Treatment Business (2018-2023)
Figure 51. Baxter International Revenue Growth Rate in Neutropenia Biologic Drug Treatment Business (2018-2023)
Figure 52. Cellerant Therapeutics Revenue Growth Rate in Neutropenia Biologic Drug Treatment Business (2018-2023)
Figure 53. Dong-A ST Co.,Ltd. Revenue Growth Rate in Neutropenia Biologic Drug Treatment Business (2018-2023)
Figure 54. Myelo Therapeutics GmbH Revenue Growth Rate in Neutropenia Biologic Drug Treatment Business (2018-2023)
Figure 55. Sanofi Revenue Growth Rate in Neutropenia Biologic Drug Treatment Business (2018-2023)
Figure 56. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Neutropenia Biologic Drug Treatment Business (2018-2023)
Figure 57. Kyowa Kirin Revenue Growth Rate in Neutropenia Biologic Drug Treatment Business (2018-2023)
Figure 58. CVS Health Revenue Growth Rate in Neutropenia Biologic Drug Treatment Business (2018-2023)
Figure 59. Partner Therapeutics Revenue Growth Rate in Neutropenia Biologic Drug Treatment Business (2018-2023)
Figure 60. Enzychem Lifesciences Corporation Revenue Growth Rate in Neutropenia Biologic Drug Treatment Business (2018-2023)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed